Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

Journal of Clinical Oncology

Volumn 26, Issue 22, 2008, Pages 3672-3680

  Adam, René ^a   de Haas, Robbert J ^a   Wicherts, Dennis A ^a   Aloia, Thomas A ^a   Delvart, Valérie ^a   Azoulay, Daniel ^a   Bismuth, Henri ^a   Castaing, Denis ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ABDOMINAL INFECTION; ADULT; ARTICLE; BILE LEAKAGE; BLEEDING; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; COLORECTAL LIVER METASTASES; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INSTITUTIONAL CARE; INTRAOPERATIVE PERIOD; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT RESPONSE; UNIVARIATE ANALYSIS; ADJUVANT THERAPY; AGE; AGED; COLORECTAL TUMOR; LIVER TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TIME; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 49249085051     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.7297     Document Type: Article

References (46)

1. Adam R, Pascal G, Azoulay D, et al: Liver resection for colorectal metastases: The third hepatectomy. Ann Surg 238:871-883, 2003
2. Fong Y, Cohen AM, Fortner JG, et al: Liver resection for colorectal metastases. J Clin Oncol 15:938-946, 1997
3. Iwatsuki S, Dvorchik I, Madariaga JR, et al: Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system. J Am Coll Surg 189:291-299, 1999
4. Nordlinger B, Guiguet M, Vaillant JC, et al: Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients - Association Française de Chirurgie. Cancer 77:1254-1262, 1996
5. Scheele J, Stangl R, Altendorf-Hofmann A, et al: Resection of colorectal liver metastases. World J Surg 19:59-71, 1995
6. Adam R, Laurent A, Azoulay D, et al: Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 232:777-785, 2000
7. Azoulay D, Eshkenazy R, Andreani P, et al: In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg 241:277-285, 2005
8. Azoulay D, Andreani P, Maggi U, et al: Combined liver resection and reconstruction of the supra-renal vena cava: The Paul Brousse experience. Ann Surg 244:80-88, 2006
9. Hemming AW, Reed AI, Langham MR Jr, et al: Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg 239:712-719, 2004
10. Adam R, Delvart V, Pascal G, et al: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 240:644-657, 2004
11. Giacchetti S, Itzhaki M, Gruia G, et al: Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10:663-669, 1999
12. Beckurts KT, Hölscher AH, Thorban S, et al: Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 84:1081-1084, 1997
13. Chang AE, Schneider PD, Sugarbaker PH, et al: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685-693, 1987
14. Ekberg H, Tranberg KG, Andersson R, et al: Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73:727-731, 1986
15. Elias D, Saric J, Jaeck D, et al: Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg 83:942-945, 1996
16. Elias D, Ouellet JF, Bellon N, et al: Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567-574, 2003
17. Gayowski TJ, Iwatsuki S, Madariaga JR, et al: Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors. Surgery 116:703-710, 1994
18. Jaeck D, Nakano H, Bachellier P, et al: Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: A prospective study. Ann Surg Oncol 9:430-438, 2002
19. Jamison RL, Donohue JH, Nagorney DM, et al: Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 132:505-510, 1997
20. Kokudo N, Sato T, Seki M, et al: Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer. Dis Colon Rectum 42:1285-1290, 1999
21. Minagawa M, Makuuchi M, Torzilli G, et al: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: Long-term results. Ann Surg 231:487-499, 2000
22. Nakamura S, Suzuki S, Konno H: Resection of hepatic metastases of colorectal carcinoma: 20 years' experience. J Hepatobiliary Pancreat Surg 6:16-22, 1999
23. Nordlinger B, Jaeck D, Guiguet M, et al: Résection chirurgicale des métastases hépatiques: Enquête de L' Association Française de Chirurgie, in Nordlinger B, Jaeck D (eds): Métastases Hépatiques des Cancers Colo-rectaux. Paris, France, Springer-Verlag, 1992, pp 141-159
24. Ohlsson B, Stenram U, Tranberg KG: Resection of colorectal liver metastases: 25-year experience. World J Surg 22:268-276, 1998
25. Rosen CB, Nagorney DM, Taswell HF, et al: Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:493-504, 1992
26. Yasui K, Hirai T, Kato T, et al: A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg 226:582-586, 1997
27. Poston GJ, Adam R, Alberts S, et al: Onco-Surge: A strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23:7125-7134, 2005
28. Elias D, Sideris L, Pocard M, et al: Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 11:274-280, 2004
29. Elias D, Liberale G, Vernerey D, et al: Hepatic and extrahepatic colorectal metastases: When resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12:900-909, 2005
30. Falcone A, Masi G, Allegrini G, et al: Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil, and leucovorin: A pilot study in patients with metastatic colorectal cancer. J Clin Oncol 20:4006-4014, 2002
31. Köhne CH, van Cutsem E, Wils J, et al: Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. J Clin Oncol 23:4856-4865, 2005
32. Tournigand C, André T, Achille E, et al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 22:229-237, 2004
33. Alberts SR, Horvath WL, Sternfeld WC, et al: Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group phase II study. J Clin Oncol 23:9243-9249, 2005
34. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947, 2000
35. Douillard JY, Cunningham D, Roth AD, et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial. Lancet 355:1041-1047, 2000
36. Giacchetti S, Perpoint B, Zidani R, et al: Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136-147, 2000
37. Saltz LB, Cox JV, Blanke C, et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343:905-914, 2000
38. Cunningham D, Humblet Y, Siena S, et al: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337-345, 2004
39. Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342, 2004
40. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000
41. Bismuth H: Surgical anatomy and anatomical surgery of the liver. World J Surg 6:3-9, 1982
42. Couinaud C: Le Foie: Études Anatomiques et Chirurgicales. Paris, France, Masson et Cie, 1957
43. Azoulay D, Castaing D, Smail A, et al: Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480-486, 2000
44. Sobin LH, Wittekind CH: TNM Classification of Malignant Tumors (ed 6). Hoboken, NJ, John Wiley & Sons, 2002
45. Wiering B, Krabbe PF, Jager GJ, et al: The impact of fluor-18- deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 104:2658-2670, 2005
46. Yang YY, Fleshman JW, Strasberg SM: Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases. J Gastrointest Surg 11:929-944, 2007